Lithium hexamethyl disilazide solution - 1 M in tert-butyl methyl ether
CAS:
Ref. 3D-FL146829
Produktinformation
Name:Lithium hexamethyl disilazide solution - 1 M in tert-butyl methyl ether
Synonyme:
- 1,1,1,3,3,3-Hexamethyldisilazane lithium saltLithium bis(trimethylsilyl)amide
Marke:Biosynth
Beschreibung:Lithium hexamethyl disilazide solution is an inhibitor drug that blocks the synthesis of pyrimidine compounds. It has been shown to be effective in congestive heart failure, hyperproliferative diseases such as pancreatitis and dyslipoproteinemia, coronary heart diseases, and HIV infection. Lithium hexamethyl disilazide solution binds to the cb2 receptor on the surface of activated T cells, which inhibits their ability to cause inflammation or autoimmune disease. This drug also has nitrogen atoms that are reactive and asymmetric, making it a good candidate for an inhibitor drug.
Hinweis:Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Chemische Eigenschaften
Molekulargewicht:167.33 g/mol
Formel:C6H18LiNSi2
Reinheit:Min. 95%